Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
HDB arrives at its Q2 fiscal 2027 results today with the same relaxed market positioning that characterised the run-up four days ago, and a stock that has added further ground since.
The share price has climbed 7% over the past week to $23.84, building on the 5.6% gain over the past month. That rally has done nothing to agitate the borrow market. Availability remains essentially unlimited, with more than 99 shares available to borrow for every one currently lent out, the same loose condition that has prevailed throughout October. Cost to borrow is 0.47%, up modestly on the week but still negligible in absolute terms. Short interest ticked up around 38% in share count over the past month, yet the absolute position remains trivial for a bank of this scale. There is no squeeze pressure, no borrow squeeze dynamic, nothing in the lending market that suggests bears are pressing a meaningful bet.
Options confirm the same story. The put/call ratio is 0.31, marginally below its 20-day average of 0.32, and the z-score of negative 0.88 points to slightly fewer puts than normal rather than any defensive surge. The 52-week high for the PCR is 1.47, making today's reading look almost indifferent by comparison. Positioning looks calm rather than complacent: call volume has quietly edged above put volume as the stock has risen.
The debate heading into the print is structural rather than tactical. Bulls point to the Q2 narrative already in circulation: 18% year-on-year net profit growth, a net interest margin around 4.2%, and declining NPA ratios, all consistent with the mid-teen earnings growth profile that has driven the 2026 re-rating. The price-to-book has moved to 1.69 and the PE to 17.4, both up on the week as the stock has run, raising the bar for the result to sustain the move. Bears, to the extent they exist here, are not expressing their view through the borrow market. The more relevant tension is whether the bank can confirm that loan growth and margin stability held through the quarter, at a valuation that has expanded materially through the year.
The print will test whether the operational momentum behind HDFC Bank's 2026 re-rating is robust enough to justify a stock trading at its highest levels in months.
See the live data behind this article on ORTEX.
Open HDB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
